Company Summary :
Clarity CX1 product is a SaaS solution for account management teams in Pharma and Life Science companies. The CX1 software sits on the Salesforce.com Lightning Platform and was designed in collaboration with target pharma companies already in consulting and e-learning relationships with CX1 founders.
- Clarity CX1 just became a Salesforce.com ISV Partner and recently received final security/data approval to go live on the Salesforce app store/solutions list.
- Product is due to trial on three major beta site projects; Takeda, Allergan, Novartis
- Two Specialist VC investors + angel funds investing €900,000.
- Spark investors can invest on exact same terms.
- Addressable market for customer engagement software is worth €11 billion per annum
- Clarity CX1 management team is projecting Monthly Recurring Revenues of €75,000 per month by the end of 2021.